Improving survey methods in sero-epidemiological studies of injecting drug users: A case example of two cross sectional surveys in Serbia and Montenegro

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Judd, Ali ^a   Rhodes, Tim ^b   Johnston, Lisa G ^c   Platt, Lucy ^b   Andjelkovic, Violeta ^d   Simić, Danijela ^e   Mugosa, Boban ^f   Simić, Milena ^g   Žerjav, Sonja ^h   Parry, Ruth P ⁱ   Parry, John V ^b,i  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c TULANE UNIVERSITY   (United States)

^d International Aid Network   (Serbia)

^e Institute of Public Health of Serbia   (Serbia)

^f Institute of Public Health   (Montenegro)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

^h UNIVERSITY OF BELGRADE   (Serbia)

ⁱ PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ALGORITHM; ANTIBODY DETECTION; ARTICLE; COMMUNITY SAMPLE; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; EPIDEMIOLOGICAL DATA; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; INTRAVENOUS DRUG ABUSE; MONTENEGRO (REPUBLIC); NONHUMAN; PREDICTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SERBIA; SEROPREVALENCE; VIRUS TRANSMISSION; ANONYMOUS TESTING; BLOOD; DRUG USE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MALE; PREVALENCE; SERODIAGNOSIS; SUBSTANCE ABUSE;

ADULT; AIDS SERODIAGNOSIS; ANONYMOUS TESTING; CROSS-SECTIONAL STUDIES; DRUG USERS; FEMALE; HEALTH SURVEYS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; MALE; MONTENEGRO; PREVALENCE; RISK FACTORS; SERBIA; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 61649121558     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-14     Document Type: Article

References (38)

1. Hamers FF Downs AM HIV in central and eastern Europe Lancet 2003, 361(9362):1035-1044. 10.1016/S0140-6736(03)12831-0 12660072
2. Rhodes T Lowndes C Judd A Mikhailova LA Sarang A Rylkov A Tichonov M Lewis K Ulyanova N Alpatova T, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia AIDS 2002, 16(13):F25-31. 10.1097/00002030-200209060-00002 12218407
3. Rhodes T Simic M Transition and the HIV risk environment BMJ 2005, 331(7510):220-223. 1179776 16037463 10.1136/bmj.331.7510.220
4. Aceijas C Rhodes T Global estimates of prevalence of HCV infection among injecting drug users Int J Drug Policy 2007, 18(5):352-358. 10.1016/ j.drugpo.2007.04.004 17854722
5. Cobic P Keserovic N Radovanovic Z Dobec M Bjeljac ZS Jung M Prelic A Vukov M Baba-Milkic N Gledovic Z HIV-1 and HTLV-1 infections among intravenous drug abusers in Belgrade, Yugoslavia J Acquir Immune Defic Syndr 1990, 3(12):1197-1199. 2243321
6. Kilibarda M HIV infection among drug abusers in the Belgrade area Bulletin on Narcotics 1993, 45(1):135-146. 8305903
7. EuroHIV HIV/AIDS surveillance in Europe. End-year report 2006. No. 75 Saint-Maurice: Institut de Veille Sanitaire 2007.
8. Rhodes T Prodanovic A Zikic B Kuneski E Pavicevic T Karadzic D Bernays S Trust, disruption and responsibility in accounts of injecting equipment sharing and hepatitis C risk Health, Risk and Society 2008, 10:221-240. 10.1080/13698570802160921
9. Rhodes T Zikic B Prodanovic A Kuneski E Bernays S Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia Soc Sci Med 2008, 66(6):1437-1447. 10.1016/ j.socscimed.2007.11.009 18201809
10. Heckathorn DD Respondent-driven sampling: A new approach to the study of hidden populations Social Problems 1997, 44(2):174-199. 10.1525/ sp.1997.44.2.03x0221m
11. Erickson BH Some problems of inference from chain data Sociological Methodology 1979, 10:276-302. 10.2307/270774
12. Malekinejad M Johnston LG Kendall C Kerr LGFS Rifkin M Rutherford GW Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: A systematic review AIDS Behav 12(4 Suppl):S105-S130. 18561018
13. Heckathorn DD Respondent-driven sampling II: Deriving valid population estimates from chain referral samples of hidden populations Social Problems 2002, 49(1):11-34. 10.1525/sp.2002.49.1.11
14. Salganik MJ Heckathorn D Sampling and estimation in hidden populations using respondent-driven sampling Sociological Methodology 2004, 34(1):193-240. 10.1111/j.0081-1750.2004.00152.x
15. Johnston LG Malekinejad M Kendall C Iuppa IM Rutherford GW Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: Field experiences in international settings AIDS and Behavior 2008, 12(4 Suppl):S131-141. 10.1007/s10461-008-9413-1
16. Scott G "They got their program, and I got mine": A cautionary tale concerning the ethical implications of using respondent-driven sampling to study injection drug users Int J Drug Policy 2008, 19(1):42-51. 10.1016/j.drugpo.2007.11.014 18226516
17. Sullivan PS Lansky A Drake A Failure to return for HIV test results among persons at high risk for HIV infection: Results from a multistate interview project JAIDS 2004, 35(5):511-518. 15021316
18. Respess RA Rayfield MA Dondero TJ Laboratory testing and rapid HIV assays: Applications for HIV surveillance in hard-to-reach populations AIDS 2001, 15(Suppl 3):S49-59. 10.1097/00002030-200104003-00007 11421183
19. Turner CF Ku L Rogers SM Lindberg LD Pleck JH Sonenstein FL Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology Science 1998, 280(5365):867-873. 10.1126/ science.280.5365.867 9572724
20. Des Jarlais DC Paone D Milliken J Turner CF Miller H Gribble J Shi Q Hagan H Friedman SR Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial Lancet 1999, 353(9165):1657-1661. 10.1016/S0140-6736(98)07026-3 10335785
21. Centers for Disease Control and Prevention Rapid HIV testing in outreach and other community settings - United States, 2004-2006 MMWR 2007, 56(47):1233-1237. 18046300
22. Stetler HC Granade TC Nunez CA Meza R Terrell S Amador L George JR Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras AIDS 1997, 11(3):369-375. 10.1097/ 00002030-199703110-00015 9147429
23. San Antonio-Gaddy M Richardson-Moore A Burstein GR Newman DR Branson BM Birkhead GS Rapid HIV antibody testing in the New York State Anonymous HIV Counseling and Testing Program: Experience from the field JAIDS 2006, 43(4):446-450. 16980908
24. Bucher JB Thomas KM Guzman D Riley E Dela Cruz N Bangsberg DR Community-based rapid HIV testing in homeless and marginally housed adults in San Francisco HIV Med 2007, 8(1):28-31. 10.1111/ j.1468-1293.2007.00423.x 17305929
25. Viani RM Hubbard P Ruiz-Calderon J Araneta MR Lopez G Chacon-Cruz E Spector SA Performance of rapid HIV testing using Determine HIV-1/2 for the diagnosis of HIV infection during pregnancy in Tijuana, Baja California, Mexico Int J STD AIDS 2007, 18(2):101-104. 10.1258/ 095646207779949655 17331281
26. Gray RH Makumbi F Serwadda D Lutalo T Nalugoda F Opendi P Kigozi G Reynolds SJ Sewankambo NK Wawer MJ Limitations of rapid HIV-1 tests during screening for trials in Uganda: Diagnostic test accuracy study BMJ 2007, 335(7612):188. 17545184 1934458 10.1136/bmj.39210.582801.BE
27. Judd A Hickman M Jones S McDonald T Parry JV Stimson GV Hall AJ Incidence of hepatitis C virus and HIV among new injecting drug users in London: Prospective cohort study BMJ 2005, 330(7481):24-25. 539846 15533854 10.1136/bmj.38286.841227.7C
28. Judd A Parry J Hickman M McDonald T Jordan L Lewis K Contreras M Dusheiko G Foster G Gill N, et al Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots J Med Virol 2003, 71(1):49-55. 10.1002/jmv.10463 12858408
29. Connell JA Parry JV Mortimer PP Duncan J Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine J Med Virol 1993, 41(2):159-164. 10.1002/jmv.1890410212 8283178
30. Tamashiro H Constantine NT Serological diagnosis of HIV infection using oral fluid samples Bull World Health Organ 1994, 72(1):135-143. 8131250
31. Connell JA Parry JV Detection of anti-HIV in saliva and urine at the time of seroconversion Clin Diagn Virol 1994, 1:299-311. 10.1016/ 0928-0197(94)90060-4 15566744
32. World Health Organization HIV simple/rapid assays: Operational characteristics (Phase 1). Report 12 whole blood specimens Geneva: World Health Organization 2002.
33. Heckathorn DD Semaan S Broadhead RS Hughes JJ Extensions of respondent-driven sampling: A new approach to the study of injection drug users aged 18-25 AIDS and Behavior 2002, 6(1):55-67. 10.1023/ A:1014528612685
34. Horton NJ Kleinman KP Much ado about nothing: A comparison of missing data methods and software to fit incomplete data regression models The American Statistician 2007, 61(1):79-90. 1839993 17401454 10.1198/ 000313007X172556
35. Sutton AJ Hope VD Mathei C Mravcik V Sebakova H Vallejo F Suligoi B Brugal MT Ncube F Wiessing L, et al. A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: A modelling study J Viral Hepat 2008, 15(11):809-816. 18761605
36. Rhodes T Treloar C The social production of hepatitis C risk among injecting drug users: A qualitative synthesis Addiction 2008, 103(10):1593-1603. 10.1111/j.1360-0443.2008.02306.x 18821870
37. Rhodes T Prodanovic A Zikic B Kuneski E Bernays S Trust, disruption and responsibility in accounts of injecting equipment sharing and hepatitis C risk in Serbia and Montenegro Health, Risk and Society.
38. Joint United Nations Programme on HIV/AIDS (UNAIDS) - WHO Revised recommendations for the selection and use of HIV antibody tests WER 1997, 72:81-88. 9238418